Showing results (691-700 of 834) with videos related to
Sort By:
Pageof 84
Kidney International Reports|March 8, 2022
The Kidney Protective Effects of the Sodium-Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor AntagonistsMichele Provenzano, Niels Jongs, Priya Vart, et al.JAMA|September 2, 2015
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical TrialGeorge L Bakris, Rajiv Agarwal, Juliana C Chan, et al.Diabetes Technology & Therapeutics|October 24, 2024
Possible Glycemic Effects of Vagus Nerve Stimulation Evaluated by Continuous Glucose Monitoring in People with Diabetes and Autonomic Neuropathy: A Randomized, Sham-Controlled TrialHuda Kufaishi, Davide Bertoli, Ditte Smed Kornum, et al.Journal of the American Society of Nephrology : JASN|August 17, 2022
Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKDNiels Jongs, Glenn M Chertow, Tom Greene, et al.Plos Genetics|February 20, 2010
A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetesShiro Maeda, Masa-aki Kobayashi, Shin-ichi Araki, et al.Journal of the American College of Cardiology|January 6, 2026
Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both: Secondary Analysis of the CONFIDENCE Randomized TrialRajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 27, 2026
Sexual Dimorphism and Age Effects in CKD and Type 2 Diabetes in the CONFIDENCE TrialRajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.International Urology and Nephrology|June 13, 2026
Abdominal waist circumference and subcutaneous adipose tissue thickness predicts development of post-transplant diabetes mellitusMehmet Kanbay, Feyyaz H Yagmur, Bilge Karadeniz, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2025
Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trialMuthiah Vaduganathan, Jennifer B Green, Hiddo J L Heerspink, et al.Cardiovascular Research|February 21, 2020
Genome-wide association study on coronary artery disease in type 1 diabetes suggests beta-defensin 127 as a risk locusAnni A V Antikainen, Niina Sandholm, David-Alexandre Trégouët, et al.Pageof 84